803 ORAL Analysis of Blood Plasma Factors in the AVITA Phase III Randomized Study of Bevacizumab (bev) With Gemcitabine-Erlotinib (GE) in Patients (pts) With Metastatic Pancreatic Cancer (mPC)

Eric Van Cutsem, Gordon C. Jayson, Caroline Dive, P. Dilba, Sanne de Haas, Norbert Wild, Paul Delmar, S.J. Scherer

European Journal of Cancer · 2011 · 30 citations · 0 references

Concepts